Keynote-046 (Part B): Effects Of Adxs-Psa In Combination With Pembrolizumab On Survival In Metastatic, Castration-Resistant Prostate Cancer Patients With Or Without Prior Exposure To Docetaxel

Mark N. Stein,Lawrence Fong,Anthony E. Mega,Elaine Tat Lam, John W. Heyburn,Andres A. Gutierrez,Megan Parsi,Surya Vangala,Naomi B. Haas

JOURNAL OF CLINICAL ONCOLOGY（2020）

引用 5|浏览46

暂无评分

摘要

126Background: ADXS-PSA, an attenuated Listeria monocytogenes-based immunotherapy targeting prostate-specific antigen (PSA), is currently being evaluated in combination with pembrolizumab as a trea...

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要